{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:28:11Z","timestamp":1786512491534,"version":"build-2736575974"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite advances in colorectal cancer (CRC) treatment, the chromosomal instability (CIN)-positive subgroup remains refractory to conventional therapies and immunotherapy. C2orf76, a poorly characterized gene identified as a CIN-linked candidate in CRC through bioinformatic analyses, has been associated with favorable prognosis and potential immune-related functions. However, its biological roles and underlying mechanisms in CRC remain largely unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To investigate the role of C2orf76, we generated knockout (KO), overexpression (OE), and rescue (RE) cell lines in CRC models. We performed RNA-seq, RT-qPCR, and Western blotting to examine transcriptomic and protein-level changes. Functional assays included proliferation, migration, cisplatin sensitivity, pyroptosis (GSDME cleavage), cytokinesis-block micronucleus assay (CBMN) for CIN, and \u03b3-H2AX foci detection for DNA double-strand breaks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Unexpectedly, C2orf76 KO suppressed proliferation and migration, contradicting its favorable prognostic association and suggesting a complex regulatory role. RNA-seq revealed altered genes involved in chromosome segregation, cell cycle, platinum resistance, P53 signaling, and oncogenic pathways. RT-qPCR validated changes in chromosomal stability-related genes CDT1 and FOXM1, which were further verified by Western blotting. Further experiments showed that KO inhibited cisplatin-induced pyroptosis and cleavage of GSDME, whereas OE promoted migration and enhanced cisplatin sensitivity. The CBMN assay confirmed that C2orf76 significantly impacts chromosomal instability levels in CRC cells. C2orf76 KO cells also exhibited elevated \u03b3-H2AX foci after cisplatin treatment. Rescue of C2orf76 expression reversed the KO-induced suppression of proliferation and migration, restored cisplatin sensitivity and pyroptosis, and reduced chromosomal instability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings unveil a context-dependent duality of C2orf76: knockout increases CIN, reduces proliferation and migration, but promotes chemoresistance; overexpression enhances cisplatin-induced pyroptosis and drug sensitivity yet increases migration. Thus, C2orf76 establishes a functional link between CIN, cell death, and therapeutic response, positioning it as a tunable target that may require context-dependent modulation for effective CRC intervention. This study not only characterizes a previously understudied gene but also provides a mechanistic framework for understanding how CIN-associated genes can exert opposing effects on tumor progression and treatment outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1866584","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:43:03Z","timestamp":1786509783000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The chromosomal instability associated gene C2orf76 exerts dual roles in colorectal cancer through pyroptosis and chemotherapy response"],"prefix":"10.3389","volume":"16","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pathogen Biology, Naval Medical University","place":["Shanghai, China"]},{"name":"Department of Pathology, Faculty of Medical lmaging, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Song","sequence":"additional","affiliation":[{"name":"School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinjie","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Rui","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, College of Basic Medicine, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqiang","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, College of Basic Medicine, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingguang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-00445-1","article-title":"Rising incidence of early-onset colorectal cancer - a call to action","volume":"18","author":"Akimoto","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1024\/0040-5930\/a001046","article-title":"Hereditary colorectal cancer: clinics, diagnostics and management","volume":"75","author":"Heinimann","year":"2018","journal-title":"Ther Umsch"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/edbk_349811","article-title":"Immunotherapy for microsatellite stable colorectal cancers: challenges and novel therapeutic avenues","volume":"42","author":"Sahin","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meeting"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010286","article-title":"Genetic and epigenetic biomarkers of immune checkpoint blockade response","volume":"9","author":"Xiao","year":"2020","journal-title":"J Clin Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010000","article-title":"Targeting pyroptosis reverses Kiaa1199-mediated immunotherapy resistance in colorectal cancer","volume":"13","author":"Li","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.38.6490","article-title":"Chromosomal instability (Cin) phenotype, Cin high or Cin low, predicts survival for colorectal cancer","volume":"30","author":"Watanabe","year":"2012","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179936","article-title":"Delving into the heterogeneity of different breast cancer subtypes and the prognostic models utilizing scrna-seq and bulk rna-seq","volume":"23","author":"Xu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061698","article-title":"Transcriptomic context of Runx3 expression in monocytes: a cross-sectional analysis","volume":"11","author":"Dybska","year":"2023","journal-title":"Biomedicines"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003622","article-title":"Comparative anatomy of chromosomal domains with imprinted and non-imprinted allele-specific DNA methylation","volume":"9","author":"Paliwal","year":"2013","journal-title":"PloS Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.devcel.2021.07.006","article-title":"Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy","volume":"56","author":"Ippolito","year":"2021","journal-title":"Dev Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0811835106","article-title":"Chromosomal instability determines taxane response","volume":"106","author":"Swanton","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"Davoli","year":"2017","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ng1861","article-title":"A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers","volume":"38","author":"Carter","year":"2006","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw612","article-title":"Cyclin D mediates tolerance of genome-doubling in cancers with functional P53","volume":"28","author":"Crockford","year":"2017","journal-title":"Ann Oncol Off J Eur Soc For Med Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.08.027","article-title":"The multifaceted role of chromosomal instability in cancer and its microenvironment","volume":"174","author":"Bakhoum","year":"2018","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04847-2","article-title":"Cgas-Sting drives the Il-6-dependent survival of chromosomally instable cancers","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1430469","article-title":"Apoptosis, autophagy, ferroptosis, and pyroptosis in cisplatin-induced ototoxicity and protective agents","volume":"15","author":"Dai","year":"2024","journal-title":"Front Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.60292","article-title":"Cisplatin induces pyroptosis via activation of Meg3\/Nlrp3\/Caspase-1\/Gsdmd pathway in triple-negative breast cancer","volume":"17","author":"Yan","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases","volume":"277","author":"Man","year":"2017","journal-title":"Immunol Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41420-025-02437-5","article-title":"Targeting Kif18a triggers antitumor immunity and enhances efficiency of Pd-1 blockade in colorectal cancer with chromosomal instability phenotype","volume":"11","author":"Liu","year":"2025","journal-title":"Cell Death Discov"},{"key":"B24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrc2584","article-title":"P53 polymorphisms: cancer implications","volume":"9","author":"Whibley","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","article-title":"Therapeutic targeting of P53: all mutants are equal, but some mutants are more equal than others","volume":"15","author":"Sabapathy","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2907272","article-title":"Unraveling the role of Tp53 in colorectal cancer therapy: from wild-type regulation to mutant","volume":"29","author":"Li","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.04.017","article-title":"Antagonistic effects of P53 and Hif1a on Microrna-34a regulation of Ppp1r11 and Stat3 and hypoxia-induced epithelial to mesenchymal transition in colorectal cancer cells","volume":"153","author":"Li","year":"2017","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105195","article-title":"Regulation of DNA replication licensing and re-replication by Cdt1","volume":"22","author":"Zhang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/path.6017","article-title":"Cdt1 overexpression drives colorectal carcinogenesis through origin overlicensing and DNA damage","volume":"259","author":"Petropoulos","year":"2023","journal-title":"J Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020251","article-title":"Pan-cancer analyses reveal genomic features of Foxm1 overexpression in cancer","volume":"11","author":"Barger","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1217","article-title":"Foxm1 is required for execution of the mitotic programme and chromosome stability","volume":"7","author":"Laoukili","year":"2005","journal-title":"Nat Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41419-023-05946-2","article-title":"Foxm1 is critical for the fitness recovery of chromosomally unstable cells","volume":"14","author":"Pan","year":"2023","journal-title":"Cell Death Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-45","article-title":"Upregulation of Foxm1 induces genomic instability in human epidermal keratinocytes","volume":"9","author":"Teh","year":"2010","journal-title":"Mol Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1053\/j.gastro.2017.02.018","article-title":"Induction of chromosome instability by activation of Yes-associated protein and Forkhead box M1 in liver cancer","volume":"152","author":"Weiler","year":"2017","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.268","article-title":"Fbxo31 protects against genomic instability by capping Foxm1 levels at the G2\/M transition","volume":"36","author":"Jeffery","year":"2017","journal-title":"Oncogene"},{"key":"B36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1158\/1541-7786.Mcr-09-0432","article-title":"Foxm1 confers acquired cisplatin resistance in breast cancer cells","volume":"8","author":"Kwok","year":"2010","journal-title":"Mol Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13046-025-03308-8","article-title":"Decoding chromosomal instability insights in Crc by integrating omics and patient-derived organoids","volume":"44","author":"Papaccio","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2011.07.003","article-title":"The aneuploidy paradox: costs and benefits of an incorrect karyotype","volume":"27","author":"Sheltzer","year":"2011","journal-title":"Trends Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.12.004","article-title":"Single-chromosome gains commonly function as tumor suppressors","volume":"31","author":"Sheltzer","year":"2017","journal-title":"Cancer Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.devcel.2021.07.009","article-title":"Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies","volume":"56","author":"Lukow","year":"2021","journal-title":"Dev Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trecan.2021.09.002","article-title":"Chromosomal instability and aneuploidy as causes of cancer drug resistance","volume":"8","author":"Lukow","year":"2022","journal-title":"Trends Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1038\/s41467-018-06567-6","article-title":"Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy","volume":"9","author":"Smeets","year":"2018","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-024-01259-9","article-title":"Decoding P53 tumor suppression: a crosstalk between genomic stability and epigenetic control","volume":"32","author":"Janic","year":"2025","journal-title":"Cell Death Differ"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102296","article-title":"The role of P53 dysfunction in colorectal cancer and its implication for therapy","volume":"13","author":"Michel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz7548","article-title":"Granzyme a from cytotoxic lymphocytes cleaves Gsdmb to trigger pyroptosis in target cells","volume":"368","author":"Zhou","year":"2020","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112863","article-title":"Foxm1-activated Sirt4 inhibits Nf-Kb signaling and Nlrp3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy","volume":"408","author":"Xu","year":"2021","journal-title":"Exp Cell Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202702","article-title":"Foxm1 inhibition enhances the therapeutic outcome of lung cancer immunotherapy by modulating Pd-L1 expression and cell proliferation","volume":"9","author":"Madhi","year":"2022","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1016\/j.cell.2023.11.006","article-title":"Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors","volume":"186","author":"Heiser","year":"2023","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3161","article-title":"Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(17)30516-8","article-title":"Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis","volume":"18","author":"Turajlic","year":"2017","journal-title":"Lancet Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.198","article-title":"Determinants and clinical implications of chromosomal instability in cancer","volume":"15","author":"Sansregret","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.17179\/excli2017-948","article-title":"Microsatellite instability in colorectal cancer","volume":"17","author":"Nojadeh","year":"2018","journal-title":"Excli J"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/postmj\/qgad136","article-title":"Immunotherapy of microsatellite stable colorectal cancer: resistance mechanisms and treatment strategies","volume":"100","author":"Han","year":"2024","journal-title":"Postgrad Med J"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1462496","article-title":"Genomic instability as a driver and suppressor of anti-tumor immunity","volume":"15","author":"Requesens","year":"2024","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.895961","article-title":"Chromosome instability and aneuploidy as context-dependent activators or inhibitors of antitumor immunity","volume":"13","author":"Kuang","year":"2022","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00923-w","article-title":"Targeting chromosomal instability in patients with cancer","volume":"21","author":"Al-Rawi","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.88054","article-title":"Chromosomal instability induced in cancer can enhance macrophage-initiated immune responses that include anti-tumor Igg","volume":"12","author":"Hayes","year":"2024","journal-title":"Elife"},{"key":"B60","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13046-025-03513-5","article-title":"Trim6 ablation reverses Icb resistance in Mss gastric cancer by unleashing Cgas-Sting-dependent antitumor immunity","volume":"44","author":"Niu","year":"2025","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1866584\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:43:06Z","timestamp":1786509786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1866584\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":60,"alternative-id":["10.3389\/fonc.2026.1866584"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1866584","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1866584"}}